2021
DOI: 10.1111/bph.15600
|View full text |Cite
|
Sign up to set email alerts
|

Activation of AMP kinase ameliorates kidney vascular dysfunction, oxidative stress and inflammation in rodent models of obesity

Abstract: Background and Purpose: Obesity is a risk factor for the development of chronic kidney disease independent of diabetes, hypertension and other co-morbidities.Obesity-associated nephropathy is linked to dysregulation of the cell energy sensor AMP-activated protein kinase (AMPK). We aimed here to assess whether impairment of AMPK activity may cause renal arterial dysfunction in obesity and to evaluate the therapeutic potential of activating renal AMPK.Experimental Approach: Effects of the AMPK activator A769662 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 75 publications
0
5
0
1
Order By: Relevance
“…AMP-activated protein kinase (AMPK), as a sensor of energy molecules, is closely associated with metabolic stress, diabetes and vascular disorders [ 31 , 32 , 33 , 34 , 35 , 36 ]. In VSMCs, AMPK activation also involves the improvement of oxidative stress, inflammation and calcification [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…AMP-activated protein kinase (AMPK), as a sensor of energy molecules, is closely associated with metabolic stress, diabetes and vascular disorders [ 31 , 32 , 33 , 34 , 35 , 36 ]. In VSMCs, AMPK activation also involves the improvement of oxidative stress, inflammation and calcification [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Our findings demonstrate that hyperoxaluria induces ED of renal preglomerular arteries in which oxidative stress plays a pivotal role. ED and oxidative stress have been involved in the renal vascular complications of metabolic disorders leading to CKD such as diabetic nephropathy or obesity-associated kidney injury [ 6 , 7 , 20 , 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…23 Similar experimental evidence supports a direct role of adiponectin, signalling through AMP-kinase in protecting neuronal tissue 24 and kidney 25 from ischaemia-reperfusion injury, supporting the epidemiological evidence from human medicine that associates low plasma adiponectin concentrations with increased risk of stroke in patients suffering acute myocardial infarction. 26 Furthermore, obesity models in mice and rats lead to vascular dysfunction (endothelial dysfunction in particular) related to dysregulation of the AMP-kinase pathway, 27 which has been postulated to partly explain the link between obesity and non-diabetic chronic kidney disease in humans.…”
Section: Hypoxia and Oxidative Stressmentioning
confidence: 99%